To develop an integrated diagnostic platform that utilizes whole genome sequencing (WGS) to identify bacterial pathogens and predict antibiotic susceptibility directly from blood, within a few hours -…
Active Definitive Contract Awarded Last action
- Contract number
- 75N93025C00025
- Awardee
-
Genomic Labs LTD UEI NGZ6HVXE5MX4
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $3,439,742
Award facts
- Opportunity
-
- HHSNIHNIAIDBAA20241 Solicitation number
- Contract value 99% obligated
-
- $3,439,742.00 Current, with exercised options
- $3,490,083.00 Potential, with all options
- Completion date 63% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 41 offers Negotiated Proposal / Quote
- Pricing
- Cost No Fee
- Place of performance
- Great Britain, United Kingdom
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $2,439,742 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $1,000,000 |
About this award
The National Institute of Allergy and Infectious Diseases, within the Department of Health and Human Services, awarded a definitive cost-no-fee contract with a $3.49 million ceiling value to Genomic Labs LTD on September 29, 2025, with no set-aside used. The contract develops an integrated diagnostic platform that applies whole genome sequencing to identify bacterial pathogens and predict antibiotic susceptibility directly from blood within a few hours, addressing limitations of current culture-based methods.
Place of performance is Great Britain, United Kingdom. The ultimate completion date is June 27, 2027. The vendor summary in the source cites May 31, 2027 as the end date, but the structured completion date is the one stated here.
Description
To develop an integrated diagnostic platform that utilizes whole genome sequencing (WGS) to identify bacterial pathogens and predict antibiotic susceptibility directly from blood, within a few hours - addressing limitations with current culture-based
Quick answers
Who was awarded contract 75N93025C00025?
75N93025C00025 was awarded to Genomic Labs LTD by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 29, 2025.
How much is contract 75N93025C00025 worth?
The government has obligated $3,439,742 on 75N93025C00025. Its potential value, with all options, is $3,490,083.
Was contract 75N93025C00025 competed?
The extent of competition for 75N93025C00025 was full and open competition. The government received 41 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award